Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Silk Road Medical, Inc. Common Stock (SILK)

Surgical & Medical Instruments & Apparatus

https://www.silkroadmed.com

Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy while maintaining a reduction in long-term stroke risk.

1213 INNSBRUCK DR.
SUNNYVALE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/04/2019

Market Cap

1,100,926,750

Shares Outstanding

38,950,000

Weighted SO

38,945,496

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

LIVN --.--%

KIDS --.--%

LUNG --.--%

SIBN --.--%

NPCE --.--%

NARI --.--%

TMDX --.--%

OFIX --.--%

RXST --.--%

Beta

1.5250

Last Div

0.0000

Range

6.08-27.23

Chg

-0.0150

Avg Vol

1833754

Mkt Cap

1100926750

Exch

NASDAQ

Country

US

Phone

408 720 9002

DCF Diff

2.4074

DCF

52.5426

Div Yield

0.0000

P/S

5.7510

EV Multiple

-21.6033

P/FV

6.9401

Div Yield %

0.0000

P/E

-18.9877

PEG

-0.6435

Payout

0.0000

Current Ratio

7.6340

Quick Ratio

6.6939

Cash Ratio

0.7171

DSO

50.0545

DIO

220.0364

Op Cycle

270.0908

DPO

27.3767

CCC

242.7142

Gross Margin

0.7428

Op Margin

-0.3143

Pretax Margin

-0.2953

Net Margin

-0.2953

Eff Tax Rate

-0.0470

ROA

-0.2095

ROE

-0.3730

ROCE

-0.2526

NI/EBT

1.0000

EBT/EBIT

0.9396

EBIT/Rev

-0.3143

Debt Ratio

0.2888

D/E

0.5037

LT Debt/Cap

0.3299

Total Debt/Cap

0.3350

Int Coverage

-17.3807

CF/Debt

-0.4359

Equity Multi

1.7442

Rec Turnover

7.2921

Pay Turnover

13.3325

Inv Turnover

1.6588

FA Turnover

13.3858

Asset Turnover

0.7095

OCF/Share

-0.8570

FCF/Share

-0.9107

Cash/Share

4.3407

OCF/Sales

-0.1774

FCF/OCF

1.0627

CF Coverage

-0.4359

ST Coverage

-19.2932

CapEx Coverage

-15.9568

Div&CapEx Cov

-15.9568

P/BV

6.9401

P/B

6.9401

P/S

5.7510

P/E

-18.9877

P/FCF

-30.5101

P/OCF

-31.6153

P/CF

-31.6153

PEG

-0.6435

P/S

5.7510

EV Multiple

-21.6033

P/FV

6.9401

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 19, 13:35 Heart Devices Focused Silk Road Medical Stock Gets an Upgrade - Analyst Says New CEO's Initiatives Sets Stage For 'Back On Track' Benzinga Jan 19, 13:35 Heart Devices Focused Silk Road Medical Stock Gets an Upgrade - Analyst Says New CEO's Initiatives Sets Stage For 'Back On Track' Benzinga Jan 19, 07:36 Texas Instruments To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday GlobeNewswire Inc. Dec 20, 16:30 Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference Benzinga Oct 24, 11:00 Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 Benzinga Oct 24, 09:00 8 Analysts Have This to Say About Silk Road Medical Benzinga Oct 24, 09:00 8 Analysts Have This to Say About Silk Road Medical Benzinga Oct 24, 09:00 8 Analysts Have This to Say About Silk Road Medical

Revenue Product Segmentation

a